-
Cognitive impairment in the U.S. population without dementia is found in 22% of those over age 70. This is more than the number of those with Alzheimer's or other dementias alone, and needs to be recognized and addressed in our healthcare of this group.
-
Current use of antipsychotic medications by the elderly places them at increased risk for hospitalization for pneumonia.
-
12-lead ECG and lead II rhythm strip obtained from a 67-year-old man with new-onset shortness of breath.
-
Lifestyle changes such as improving diet and exercise are always the first important approach for the treatment of hyperlipidemia however, if the target LDL-C level is not achieved using statins and niacin, fibrates, and/or resins, at this time, ezetimibe should definitely be utilized to achieve these target goals if there are no specific contraindications to the use of the drug in each individual patient.
-
For those women who were randomized to estrogen plus progesterone in the Women's Health Initiative Trial, the increased risk of breast cancer has persisted since stopping the replacement therapy, but the increased risk of cardiovascular events has returned to that of the placebo group.
-
One-time screening for abdominal aortic Aneurysms (AAA) is recommended in older men, but there is little long-term data on the value of such screening, especially in women.
-
In 2007, the ACCF/AHA published a consensus statement in the Journal of the American College of Cardiology endorsing a role for coronary artery calcium scoring (CAC) in cardiovascular risk stratification.
-
Clinicians are becoming more attuned to the many complications of influenza, particularly with the high morbidity and mortality seen with H5N1 strains spreading around the world.
-
Another monoclonal antibody to TNF-a has been approved for the treatment of Crohn's Disease.
-
A product containing a commonly used antimigraine drug (sumatriptan) and a NSAID (naproxen) has been approved for the treatment of acute migraine attacks.
